vs

Side-by-side financial comparison of Inspire Medical Systems, Inc. (INSP) and LATTICE SEMICONDUCTOR CORP (LSCC). Click either name above to swap in a different company.

Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($269.1M vs $145.8M, roughly 1.8× LATTICE SEMICONDUCTOR CORP). Inspire Medical Systems, Inc. runs the higher net margin — 50.6% vs -5.2%, a 55.8% gap on every dollar of revenue. On growth, Inspire Medical Systems, Inc. posted the faster year-over-year revenue change (12.2% vs 9.3%). LATTICE SEMICONDUCTOR CORP produced more free cash flow last quarter ($44.0M vs $41.8M). Over the past eight quarters, Inspire Medical Systems, Inc.'s revenue compounded faster (28.1% CAGR vs 8.4%).

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

Lattice Semiconductor Corporation is an American semiconductor company specializing in the design and manufacturing of low power field-programmable gate arrays (FPGAs). Headquartered in the Silicon Forest area of Hillsboro, Oregon, the company also has operations in San Jose, Calif., Shanghai, Manila, Penang, and Singapore. Lattice Semiconductor has more than 1000 employees and an annual revenue of more than $660 million as of 2022. The company was founded in 1983 and went public in 1989. It ...

INSP vs LSCC — Head-to-Head

Bigger by revenue
INSP
INSP
1.8× larger
INSP
$269.1M
$145.8M
LSCC
Growing faster (revenue YoY)
INSP
INSP
+2.9% gap
INSP
12.2%
9.3%
LSCC
Higher net margin
INSP
INSP
55.8% more per $
INSP
50.6%
-5.2%
LSCC
More free cash flow
LSCC
LSCC
$2.2M more FCF
LSCC
$44.0M
$41.8M
INSP
Faster 2-yr revenue CAGR
INSP
INSP
Annualised
INSP
28.1%
8.4%
LSCC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
INSP
INSP
LSCC
LSCC
Revenue
$269.1M
$145.8M
Net Profit
$136.1M
$-7.6M
Gross Margin
86.6%
68.5%
Operating Margin
17.1%
30.7%
Net Margin
50.6%
-5.2%
Revenue YoY
12.2%
9.3%
Net Profit YoY
286.4%
14.6%
EPS (diluted)
$4.57
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSP
INSP
LSCC
LSCC
Q1 26
$145.8M
Q4 25
$269.1M
Q3 25
$224.5M
$133.3M
Q2 25
$217.1M
$124.0M
Q1 25
$201.3M
$120.2M
Q4 24
$239.7M
$117.4M
Q3 24
$203.2M
$127.1M
Q2 24
$195.9M
$124.1M
Net Profit
INSP
INSP
LSCC
LSCC
Q1 26
$-7.6M
Q4 25
$136.1M
Q3 25
$9.9M
$2.8M
Q2 25
$-3.6M
$2.9M
Q1 25
$3.0M
$5.0M
Q4 24
$35.2M
$16.5M
Q3 24
$18.5M
$7.2M
Q2 24
$9.8M
$22.6M
Gross Margin
INSP
INSP
LSCC
LSCC
Q1 26
68.5%
Q4 25
86.6%
Q3 25
85.8%
67.9%
Q2 25
84.0%
68.4%
Q1 25
84.7%
68.0%
Q4 24
85.0%
61.1%
Q3 24
84.1%
69.0%
Q2 24
84.8%
68.3%
Operating Margin
INSP
INSP
LSCC
LSCC
Q1 26
0.7%
Q4 25
17.1%
Q3 25
4.3%
-1.2%
Q2 25
-1.5%
3.8%
Q1 25
-0.7%
5.8%
Q4 24
13.3%
-10.4%
Q3 24
7.0%
5.9%
Q2 24
2.6%
18.2%
Net Margin
INSP
INSP
LSCC
LSCC
Q1 26
-5.2%
Q4 25
50.6%
Q3 25
4.4%
2.1%
Q2 25
-1.7%
2.3%
Q1 25
1.5%
4.2%
Q4 24
14.7%
14.1%
Q3 24
9.1%
5.7%
Q2 24
5.0%
18.2%
EPS (diluted)
INSP
INSP
LSCC
LSCC
Q1 26
$-0.06
Q4 25
$4.57
Q3 25
$0.34
$0.02
Q2 25
$-0.12
$0.02
Q1 25
$0.10
$0.04
Q4 24
$1.17
$0.12
Q3 24
$0.60
$0.05
Q2 24
$0.32
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSP
INSP
LSCC
LSCC
Cash + ST InvestmentsLiquidity on hand
$308.3M
$133.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$781.2M
$714.1M
Total Assets
$907.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSP
INSP
LSCC
LSCC
Q1 26
$133.9M
Q4 25
$308.3M
Q3 25
$322.6M
$117.9M
Q2 25
$300.9M
$107.2M
Q1 25
$369.2M
$127.6M
Q4 24
$445.5M
$136.3M
Q3 24
$411.0M
$124.3M
Q2 24
$439.7M
$109.2M
Stockholders' Equity
INSP
INSP
LSCC
LSCC
Q1 26
$714.1M
Q4 25
$781.2M
Q3 25
$666.5M
$706.4M
Q2 25
$677.8M
$687.0M
Q1 25
$635.7M
$707.9M
Q4 24
$689.7M
$710.9M
Q3 24
$696.6M
$703.5M
Q2 24
$638.1M
$698.8M
Total Assets
INSP
INSP
LSCC
LSCC
Q1 26
$883.1M
Q4 25
$907.3M
Q3 25
$807.7M
$844.4M
Q2 25
$802.2M
$808.6M
Q1 25
$730.8M
$823.6M
Q4 24
$808.4M
$843.9M
Q3 24
$796.2M
$853.7M
Q2 24
$728.4M
$827.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSP
INSP
LSCC
LSCC
Operating Cash FlowLast quarter
$52.5M
$57.6M
Free Cash FlowOCF − Capex
$41.8M
$44.0M
FCF MarginFCF / Revenue
15.5%
30.2%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$78.5M
$153.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSP
INSP
LSCC
LSCC
Q1 26
$57.6M
Q4 25
$52.5M
Q3 25
$68.5M
$47.1M
Q2 25
$2.7M
$38.5M
Q1 25
$-6.7M
$31.9M
Q4 24
$69.2M
$45.4M
Q3 24
$52.3M
$44.0M
Q2 24
$-78.0K
$21.9M
Free Cash Flow
INSP
INSP
LSCC
LSCC
Q1 26
$44.0M
Q4 25
$41.8M
Q3 25
$58.1M
$34.0M
Q2 25
$-6.3M
$31.3M
Q1 25
$-15.1M
$23.3M
Q4 24
$62.2M
$39.7M
Q3 24
$44.3M
$39.4M
Q2 24
$-12.5M
$14.8M
FCF Margin
INSP
INSP
LSCC
LSCC
Q1 26
30.2%
Q4 25
15.5%
Q3 25
25.9%
25.5%
Q2 25
-2.9%
25.2%
Q1 25
-7.5%
19.4%
Q4 24
25.9%
33.8%
Q3 24
21.8%
31.0%
Q2 24
-6.4%
11.9%
Capex Intensity
INSP
INSP
LSCC
LSCC
Q1 26
9.3%
Q4 25
4.0%
Q3 25
4.6%
9.8%
Q2 25
4.1%
5.8%
Q1 25
4.2%
7.2%
Q4 24
2.9%
4.9%
Q3 24
3.9%
3.7%
Q2 24
6.3%
5.8%
Cash Conversion
INSP
INSP
LSCC
LSCC
Q1 26
Q4 25
0.39×
Q3 25
6.90×
16.86×
Q2 25
13.23×
Q1 25
-2.24×
6.35×
Q4 24
1.96×
2.75×
Q3 24
2.83×
6.12×
Q2 24
-0.01×
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons